ArticleParasites & vectors2025
Consequences of insecticide overuse in Hungary: assessment of pyrethroid resistance in Culex pipiens and Aedes albopictus mosquitoes.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Current Knowledge on Insecticide Resistance inInsects · 2026Review
- Present and Future of Mosquito-Borne Disease Control in Europe with a Specific Focus on the Mediterranean.Insects · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMosquitoes, as vectors of various pathogens, have been a public health risk for centuries. Human activities such as international travel and trade, along with climate change, have facilitated the spread of invasive mosquitoes and novel pathogens across Europe, increasing the risk of mosquito-borne disease introduction and their spread. Despite this threat, mosquito control in Hungary still relies predominantly on chemical treatments, which poses the risk of developing insecticide resistance in local populations. While pyrethroid resistance has been documented in several countries, there is no information on this issue from Hungary. This study aims to investigate the presence of resistance in Hungarian mosquito populations by analyzing a native, already known disease vector and a recently established invasive species with public health significance.
methodsWe assessed the presence of knockdown resistance (kdr) mutations L1014F in Culex pipiens and V1016G and F1534C in Aedes albopictus mosquitoes, which are responsible for pyrethroid resistance. Mosquito specimens were investigated retrospectively, collected from previous years within the framework of local monitoring programs run in urban areas representing five regions of Hungary. The mutations in mosquitoes were detected individually by allele-specific polymerase chain reaction (PCR) and gel electrophoresis, following generally used protocols.
resultsIn Cx. pipiens, the kdr mutation was detected across all five collection sites, with resistance allele frequencies ranging from 18.1% to 36.3%. Resistance alleles were identified in homozygosity and heterozygosity with the susceptible allele, resulting in 53% of the investigated mosquitoes showing resistance to pyrethroids in the Hungarian populations. In contrast, for Ae. albopictus, the analyzed individuals were found to carry only the susceptible alleles, indicating a homozygous susceptible genotype across the investigated populations on the basis of V1016G and F1534C genes.
conclusionsOur work highlights the consequences of the unilateral and long-term use of chemical treatments on mosquitoes. This indicates an urgent need for a change of concept in mosquito control strategy in Hungary, as well as in countries where mosquito control still relies dominantly on insecticides. The restricted use of chemical treatment is highly recommended to prevent the development of pyrethroid resistance in recently established populations of the invasive Ae. albopictus, and to decrease the public health risk of vector-borne diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.